Cognition Therapeutics, Inc.
CGTX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $20 | $26 | $33 |
| - Cash | $40 | $11 | $16 | $25 |
| + Debt | $0 | $0 | $1 | $1 |
| Enterprise Value | – | $9 | $10 | $8 |
| Revenue | – | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$5 | -$7 | -$8 | -$8 |
| % Margin | – | – | – | – |
| Net Income | -$5 | -$7 | -$8 | -$8 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.06 | -0.11 | -0.14 | -0.17 |
| % Growth | 45.5% | 21.4% | 17.6% | – |
| Operating Cash Flow | -$6 | -$6 | -$10 | -$8 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | -$6 | -$6 | -$10 | -$8 |